top of page
peaonia-beauty-564.jpg
peaonia-beauty-563.jpg
paeonia-beauty-461-768x367.jpg
iStock-810737428.jpg
image.img.jpeg

What is the latest application example of medical AI? Doctor commentary [2020 version]
By TOKYO analytica-April 15, 2019

 

In recent years, the use of artificial intelligence (AI) has advanced rapidly in so many fields that there is no day without seeing new news about AI. The background lies in the development of Deep Learning technology, but of course the use of AI in medicine is no exception. On the other hand, medical care is a special area that directly deals with human life, so the effect of AI is a little different from other fields. This time, we will broadly explain AI in the context of medical care, what is AI in the first place, what kind of benefits it will bring, what kind of problems will be born at the same time, and the latest medical AI trends to watch I would like to introduce

1. What is AI in healthcare?
What is AI in the first place?
AI (Artificial Intelligence) literally means "artificial intelligence," but its definition varies from researcher to researcher. Roughly speaking, it is a program that reproduces the logical thinking that human beings have done on a computer. Until now, it was a very limited "intelligence" that could only give an answer under certain rules, but due to the advanced development of deep learning technology from around 2010, the program is autonomous from the given data. It became possible to build a judgment standard by learning to. This means that AI can build and classify its own criteria, even those that could not show clear criteria to humanity. What brought this system to medical treatment is the so-called “medical AI”. In medical care, even if we focus solely on the disease, many judgments such as onset risk evaluation, disease diagnosis, treatment selection, prognosis evaluation, etc. are required, but the judgment is complicated by the difference in the situation for each individual. Usually very difficult If a criterion is constructed based on a large amount of accumulated patient data and, for example, an optimal treatment method is presented for each individual, the benefits provided by medical AI will be extremely large for both patients and medical personnel. I can imagine that.

What is Deep Learning?
Deep learning is the core of recent AI technology development, but it is difficult to catch up with all of the new technologies that are being released literally day by day. Here, I will give a brief explanation of these basic terms and examples of their use in medicine.

There is an algorithm called a neural network (which shows the procedure) that has been studied since the mid-20th century. This is a model of cranial nerve cells in humans and other living organisms, and has a structure in which the layer structure such as the input layer, the hidden layer, and the output layer are connected by edges. By giving a function to each layer (called an activation function) and giving weights to edges, a very complicated model for classifying input values ​​and outputting an answer is realized. This algorithm with many hidden layers (deep) is called deep learning. By the way, machine learning refers to "iteratively learning from given data and finding appropriate rules", and deep learning is also included in this. More specifically, let's say that you want to build an algorithm that predicts the onset of diabetes one year later from the current blood glucose level, blood pressure, and body weight. By inputting 3 points of blood glucose level, blood pressure, and body weight from a database that collects a lot of patient data, and setting whether or not diabetes was developed one year later as an output, edge weights etc. are determined through repeated learning. To do. The resulting optimal algorithm, given these three points, can predict whether a person will develop diabetes one year later. Such learning of the relationship between input and output is called supervised learning, which is frequently used in AI development in medicine.

In general machine learning, the feature amount (three points of blood glucose level, blood pressure, and body weight in the above example) is arbitrarily selected and input, whereas in deep learning, the feature amount that is most useful for determining the output. Even it can be automatically extracted and learned. Convolutional neural network (CNN), which is known as a typical deep learning model, gives an image itself as an input, but it is not necessary to specify a concrete feature quantity. For example, an algorithm developed by Mayo Clinic in the United States (past article) identifies asymptomatic left ventricular dysfunction from the electrocardiogram waveform image itself. Of course, it is also possible to extract features from the electrocardiogram waveform (height/width of the waveform, etc.) and construct an equivalent algorithm, but the input information is limited by selecting any item (in the statistical field, "information Is discarded"), and it is highly possible that the accuracy of the CNN algorithm will not be exceeded. Currently, this CNN plays a leading role in the development of diagnostic imaging AI.

Medical AI is powerful but not universal
Artificial intelligence seems to imitate human intelligence, a substitute for brain function, but in many cases this is overstated. To put it simply, AI at the moment is just something that can identify something specific. That is, if the algorithm can identify the blood vessel from the image, it will be returned as "blood vessel" if the image of the artery is shown, and "not blood vessel" if the image of hair is shown. Without making any changes to this algorithm, we cannot even distinguish between a newborn and an adult. Therefore, almost all AI, which has been popular around the world, just extracts "specific and very limited functions" of human beings and reproduces them on a computer, which is not all-purpose.

However, this reproduced function is so powerful that it sometimes greatly exceeds the discrimination ability of humankind. For example, it has been reported that an algorithm for identifying pediatric diseases from electronic medical record records exceeded the diagnostic accuracy of pediatricians for multiple diseases including influenza (past article). The results of this research have been published in the prestigious academic journal Nature Medicine and have attracted attention. Also, because AI can capture even minute changes that cannot be discerned by the human eye, it is highly compatible with medical images such as malignant tumor diagnosis, and technological development in the field of radiology is remarkable (past article). In addition, AI has the advantage of continuing to deliver stable results. Particularly in Japan, there is a harsh situation where doctors' judgments are blunted, such as overload of work due to lack of personnel, frequent calls at night and on holidays, and shifts to regular work. AI support that maintains a certain level of output accuracy could be a form of insurance for doctors.

2. What medical fields can AI utilize?

Photo by iStock
Next, I would like to look at medical fields that can utilize AI. Medical treatment is roughly divided into three steps: “prevention” to prevent the onset of disease, “diagnosis” to identify people who already have the disease, and “treatment” to improve the turning point of people with a diagnosis. AI is not only able to contribute to all of these three major steps, but is also being used in medical systems, including medical insurance systems and medical provision systems, and is expected to be used in all medical fields. ing. Behind this is the lack of human resources associated with the high degree of expertise of medical professionals, and many countries are trying to find a way out for AI.

Utilizing AI in diagnostic imaging
Radiology, especially the process of diagnosing diseases from medical images is known as the most important application of medical AI. The number of medical images that require interpretation at each facility is increasing due to the development of medical peripheral technology and the aging of society, but the number of radiologists accompanying it is not sufficient. AI can directly reduce the work load by helping the radiologist's interpretation. However, it is important to know that the number of AI devices currently approved as legitimate medical devices is very limited. In other words, even if AI diagnoses that "it has a malignant tumor," at present, there is almost no progress from diagnosis to treatment without the confirmation of a doctor. This is also a problem with AI, which will be described later, but it is due to lack of verification of the validity of the algorithm and the delay in the development of laws regarding AI. No alternatives have been found.

On the other hand, it is highly likely that AI will completely replace chest X-ray interpretation and ECG analysis in medical examinations in the near future. This is because the image interpretation in the medical examination is the screening, and the definite diagnosis is obtained in the subsequent individual medical examination. False negatives (determining “no disease” despite the presence of a disease) poses a problem in screening, but adjustment of the algorithm can sufficiently avoid this problem. AI, which is capable of producing consistent results with insomnia and rest, will be positively accepted by this type of screening agency in terms of manpower and cost. Practical examples of eye disease screening in the UK and China have been introduced in the past (Past articles 1 and 2).

Utilization of AI in disease diagnosis
With the rapid development of natural language processing technology in recent years, medical record analysis has become more popular. As a result, the disease diagnosis AI based on medical records has greatly improved its accuracy. In the past, we also introduced AI for diagnosis of pediatric diseases (past article), medical chart analysis system by Amazon (past article), so please refer to it. The medical record contains not only the findings of the doctor, but also all test results and prescription records. The longer the patient's medical history, the larger the medical records will be, and it will be difficult for even a good doctor to capture all of them during the limited medical treatment time. From the aspect, the use of AI will be effective. Similarly, there is an example of developing an AI system that integrates not only medical records but also biometric sensors and monitor records (past article). This system at the University of Florida in the United States predicts serious pathological changes and the occurrence of fatal diseases in the intensive care unit (ICU), and it can be said that AI is an effective application example. Furthermore, the development of a method for more easily diagnosing diseases such as sleep apnea syndrome that require specialized tests for diagnosis by using AI is proceeding (past article).

Utilization of AI for various medical problems
Utilization of AI is not limited to actual clinical situations. It is also used for vulture journal issues that undermine the credibility of medical science (past article), for combating doping in sports (past article), and even for efforts to prevent bioterrorism (past article). ..

3. What are the problems and issues of AI in the medical field?

Photo by iStock
Lack of AI validation
Many medical researchers continue to be skeptical of AI algorithms (past articles). The opinion is that only the high accuracy of the algorithm is distracted and the essential effectiveness is left behind.

When building an algorithm, generally only one dataset is used. This data set is divided into, for example, 80% and 20%, one side is a learning set for algorithm construction, and the other is a test set. In other words, it is a method of confirming whether the algorithm derived from the learning set exhibits the same accuracy in the test set and concluding that the algorithm is valid if the accuracy is maintained. However, the true validity has not been verified by this method alone. This is because the algorithm is only derived from "a specific population data", and its accuracy may not be maintained if the target population is changed. To give a simple example, the algorithms derived from the British-centered data set are not always effective in the Japanese. In fact, Amazon's proud face recognition AI, Rekognition, is also causing a big turmoil based on the research findings that "I have a bias that I can not distinguish black women well" (see CNN). There is no doubt that precise verification based on conventional medical evidence construction, such as multi-center analysis with different target populations and prospective follow-up studies, is required.

Delay in legislation surrounding medical AI
Over the last five years, the use of AI in medical care has progressed rapidly, but the technological development has been so rapid that necessary legal arrangements have been made

Running late. As a matter of fact, there is not enough discussion about how to handle the diagnostic results shown by medical AI. At the moment, by adding the phrase "always require confirmation from a doctor", it can only be seen as being introduced as a support system in clinical settings. It is a minimum to clarify and comply with the guidelines for the construction of essentially effective algorithms, the requirements for the AI ​​system to be approved as a medical device, and certain restrictions on those without approval. It has been demanded. It is very dangerous that medical AI of unknown effectiveness is widely available on the market without any restrictions.

Medical staff lacks knowledge about AI
It cannot be prescribed without knowing the effect and mechanism of action of the drug. Similarly, medical personnel such as doctors will need some knowledge of AI in the future. The need for AI subjects as a basic education for medical students has begun to be discussed, and an example of Boston University was introduced before (past article). In the future, as AI in healthcare becomes more pervasive and will become (and likely will be) involved in all healthcare processes, it will be very difficult for healthcare professionals to avoid AI.

 

Four. Up-to-date medical AI trend of attention

Photo by iStock
Drug discovery by AI
Pharmaceutical giant GlaxoSmithKline and British startup Exscientia announced that they have discovered compounds that could be used to treat chronic obstructive pulmonary disease (COPD) (past article).
This uses an AI-based compound search platform, which could be an epoch-making act in AI drug discovery. Compared with the conventional process, using AI not only makes drug development much more efficient, but it is also effective in exposing targets that have been overlooked even though there is a possibility of drug development. I have already introduced the automatic search technology of synthetic routes by AI, so please refer to it (past article).

In February 2020, Exscientia and Sumitomo Dainippon Pharma announced that they would start phase I clinical trials of new drug candidate compounds developed using AI. The entry of AI-guided compounds into human clinical trials represents a milestone in drug discovery.

Use for diagnostic imaging at death
There is an approach called diagnostic imaging at death. The purpose is to investigate the condition and cause of death at the time of death from CT and MRI images after death (past article). It is not realistic for a radiologist who has been pointed out that there is a shortage of personnel even with biometric images, and forcing him to read images during death imaging. In addition, not many radiologists are good at reading such special areas. Utilization of AI in such situations is considered to be extremely useful. In fact, it has been pointed out that AI-based analysis of post-mortem brain MRI images of patients with neurodegenerative diseases may lead to the development of new treatment methods.

Use for medical devices
A wave of technological innovation is coming to the stethoscope, which is a traditional medical tool. StethoMe's AI stethoscope is known as an EU-certified medical device intended for home use. We are constructing a system in which abnormal breathing sounds of patients are caught early and information is shared with clinicians along with the diagnosis results by AI. StethoMe announced a partnership with major telemedicine providers in Europe in April 2020, and is expected to further expand its market share (past article).

Efforts to replace the blood sampling technique with robots have also begun. A blood sampling robot developed by a research team at Rutgers University, NJ, combines deep learning with infrared and ultrasound imaging to identify blood vessels in tissue. Then perform complex visual tasks such as motion tracking to puncture the blood vessel with the needle. It is expected that robotic vascular access will be equivalent to or superior to human procedures, such as 88.2% success rate of initial puncture even if the blood vessel is in poor condition such that veins do not stand out. article).

"Edge AI" gains importance in medical care
Cloud computing and IoT have rapidly spread in all areas, but in recent years, “edge computing” has attracted attention because data processing is performed at a location (edge) closer to the end of the system. The one that implements an AI model on an edge device close to the site is called "edge AI", and some have completed the processing from learning to inference only on the edge side without using the cloud.

So what are the advantages of introducing edge AI in healthcare? The first point is to improve network connectivity. In other words, compared to a system that performs all processing on a cloud basis, by partially entrusting the edge device with processing of a large amount of on-site data, it is possible to reduce the direct load on the host system and network. Since the stage of healthcare is not limited to urban areas where IT infrastructure is well developed, its usefulness is remarkable even in remote areas where medical depopulation is likely to occur. Further, in telemedicine and robotic surgery, which are expected to grow even more in the future, strict control of latency is indispensable. It is easily assumed that the use of edge AI will be necessary to meet the highly demanded standard.

pickup-work-img-1050x604.jpg
iStock-810737428.jpg
jure36.jpg
depositphotos_205132968-stock-illustrati
Free_Sample_By_Wix.jpeg
l.jpg
f8000ce32960521fcd7ca61fa0aa673f.jpg
1SF7871-300x200.jpg

Our comprehensive VR-based learning solutions can be used at any stage of your medical journey

Practitioners

Refine procedural techniques prior to performing certain procedures on actual patients​

Educators

No longer rely on 2D textbook images to teach concepts best understood through 3D visualization

Students

Better memorize and retain anatomy knowledge through realistic VR immersion

Patients

Better understand health conditions through immersive medical image visualization

1SF9285-300x200.jpg
1SF9341-300x200.jpg
empty-wheelchair-parked-in-hospital-pict

Comparative Effectiveness of Acupuncture and Antiarrhythmic Drugs for the Prevention of Cardiac Arrhythmias: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Yanda Li1‡, Hector Barajas-Martinez2‡, Bo Li3†‡, Yonghong Gao4, Zhenpeng Zhang1, Hongcai Shang4, Yanwei Xing1* and Dan Hu2,5*

  • 1Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, China

  • 2Masonic Medical Research Laboratory, New York, NY, United States

  • 3Xi Yuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, China

  • 4Key Laboratory of Chinese Internal Medicine of the Ministry of Education, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China

  • 5Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, China

Introduction and Objectives: This study was designed to systematically evaluate the effectiveness of acupuncture treatment for arrhythmia compared to existing drug therapy.

Methods: Randomized controlled trials (RCTs) were identified through searches of the MEDLINE, CNKI, Embase, and Cochrane databases (1970 through 2016) and hand searches of cross-references from original articles and reviews. Clinical trials that randomized arrhythmia patients to acupuncture therapy vs. conventional drugs, sham acupuncture, or bed rest were included for analysis.

Results: A total of 13 trials with 797 patients met the criteria for analysis. The results of the meta-analysis showed no statistically significant difference between acupuncture and conventional treatment for paroxysmal supraventricular tachycardia (PSVT) (n = 203; RR, 1.18; 95% CI 0.78–1.79; I2 = 80%; P = 0.44). However, in the ventricular premature beat (VPB) group, it showed a significant benefit of acupuncture plus oral administration of anti-arrhythmic drug (AAD) on response rates compared with the oral administration of AAD (n = 286; RR, 1.15; 95% CI 1.05–1.27; I2 = 0%; P = 0.002). Finally, when compared with the sinus tachycardia (ST) cases without any treatment, acupuncture has benefited these patients (n = 120; MD, 18.80, 95% CI 12.68–24.92; I2 = 81%; P < 0.00001).

Conclusions: In summary, our meta-analysis demonstrates that clinical efficacy of acupuncture is not less than AAD for PSVT. Furthermore, in sub-group analysis, acupuncture with or without AAD, shows a clear benefit in treating VPB and ST. However, more definitive RCTs are warranted to guide clinical practice.

Introduction

The 2013 overall rate of death attributable to cardiovascular diseases was 222.9 per 100,000 Americans. Among cardiovascular diseases, cardiac arrhythmia is one of the most common and serious diseases and is a serious threat to human health (Chen et al., 2013Mozaffarian et al., 2016). Arrhythmia mainly refers to the abnormal of heart impulse frequency, rhythm, origin site, conduction velocity, or the excited order. Arrhythmias include: paroxysmal supraventricular tachycardia (PSVT), sinus tachycardia (ST), ventricular premature beat (VPB), atrial fibrillation (Af), etc., (Burashnikov et al., 2012Mozaffarian et al., 2016).

Commonly used clinical treatments for arrhythmia include drug therapy, surgical intervention, and radiofrequency catheter ablation. However, all antiarrhythmic drugs have proarrhythmic effects and may cause gastrointestinal reactions, central response, hypotension, and other adverse reactions (Camm, 2017). Surgical treatment may cause serious damage and is always complex. Radiofrequency catheter ablation is characterized by a low recurrence rate and fewer complications, but it has an unsatisfactory success rate (Lomuscio et al., 2011).

In recent years, a number of clinical observations indicate that acupuncture might be an effective therapy for cardiac arrhythmias through multiple mechanisms and has the advantages of being simple, safe, inexpensive, and associated with few adverse reactions (Lomuscio et al., 2011). Recent scientific studies have examined the role that acupuncture may have as an effective intervention for cardiac arrhythmias (Kim et al., 2011Lin, 2015). Although plagued by methodological shortcomings, these studies support acupuncture as an effective treatment for atrial flutter, (Xu and Zhang, 2007Lomuscio et al., 2011) PSVT (Wu and Lin, 2006) inappropriate ST, (Xie et al., 2004) and symptomatic PVBs (Yuan and Ai, 2002Liu, 2005Zhong, 2008). Traditional Chinese Medicine (TCM) believes that the normal heartbeat relies on the “heart-qi.” Ample “heart-qi” maintains normal cardiac rhythm (Han and Wang, 2008Andrew and Mehmet, 2014).

This study was designed to systematically evaluate the use of acupuncture for arrhythmia treatments, and to evaluate the effectiveness of acupuncture treatment for arrhythmia compared to existing drug therapy.

Methods

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Ethical approval was not necessary for this review study.

Search Strategy

Studies were identified through a computerized literature search of MEDLINE, Embase, the Cochrane library and CNKI from their inception through January 2016. The search strategy terms used were as follows: (Acupuncture OR Acupuncture Therapy OR Therapy, Acupuncture) AND (Arrhythmias, Cardiac OR Cardiac Dysrhythmia OR Dysrhythmia, Cardiac OR Cardiac Arrhythmia OR Cardiac Arrhythmias OR Arrhythmia OR Arrhythmia) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR clinical trials as topic OR randomly OR trial).

Selection Criteria

RCTs were included with blind method or not and without language restriction. Trials were included if they enrolled patients with various types of cardiac arrhythmia and randomly allocated patients to receive acupuncture treatment or commonly used clinical treatments. Studies were excluded if they meet any of the following conditions: (1) Post-hoc analysis or studies without reliable outcome data; (2) Non-randomized controlled trials; (3) Auricular needling or ear acupuncture were chosen.

Observed Outcome Measures

Validity was calculated as follows: In the analysis evaluating the effectiveness of acupuncture for PSVT, Reduction of heart rate (HR) and restoration to normal sinus rhythm (NSR) were set as the outcome measures. In the analysis assessing the effectiveness of acupuncture for VPB, symptom reduction and HR reduction and % reduction of VBP on ECG or holter were set as the outcome measures. And in the analysis assessing the effect of a single acupuncture treatment in patients with ST, Reduction of HR was set as the outcome measure.

Statistical Analysis

Based on the different types of arrhythmia, we divided all of the studies into PSVT, VPB, and Af groups for assessment. The data were extracted from each of the published studies independently by two investigators. All P-values were two-tailed, with statistical significance set at 0.05, and the confidence intervals were calculated at the 95% level. Analyses were performed using Revman software version 5.3. Publication bias was detected to use funnel plots, with asymmetry suggesting possible publication bias. Publication bias was also assessed by Begg test, Egger test, and the funnel plots made using the STATA software version 12.0 for the meta-analysis. Publication bias was considered to exist if the P-value was <0.05.

Results

Baseline Characteristics

In total, 13 trials with 797 patients were available for analysis (Figure 1, Table 1Yuan and Ai, 2002Zhang and Xu, 2002Li, 2003Xie et al., 2004Liu, 2005Dong, 2006Wu and Lin, 2006Xu and Zhang, 2007Zhong, 2008Li and Guo, 2009Lomuscio et al., 2011Yuan and Zhao, 2012Wang and Zhang, 2013). Three studies evaluated the effectiveness of acupuncture for PSVT (Figure 2A). Five studies assessed the effectiveness of acupuncture plus the oral administration of AAD compared with the oral administration of AAD only for the treatment of VPB (Figure 2B). Two studies tested the effects of acupuncture on Af compared with amiodarone. Two studies assessed the effect of a single acupuncture treatment in patients with ST; both studies showed significant effects on heart rate reduction. The last RCT investigated the effects of acupuncture on patients with premature beat (PB), and the results showed significant effects of acupuncture on reducing the number of PBs. Adverse events (AEs) were reported only in XU's study (Xu and Zhang, 2007), and no AEs were noted in the acupuncture group (Xu and Zhang, 2007).

FIGURE 1

 

Figure 1. Flow diagram of the systematic review.

TABLE 1

 

Table 1. Summary of the included studies on acupuncture for cardiac arrhythmia.

FIGURE 2

 

Figure 2. Meta-analysis of the effectiveness of acupuncture treatment compared with existing therapy for several kinds of arrhythmias. (A) Acupuncture vs. conventional drug therapy for PSVT; (B) acupuncture therapy plus the oral administration of AAD vs. the oral administration of AAD alone for VPB; (C) acupuncture vs. control treatment (neither acupuncture nor any other anti-arrhythmic treatment) for ST.

Acupuncture vs. Conventional Drug Therapy for Paroxysmal Supraventricular Tachycardia

The results of the meta-analysis showed no statistically significant difference in the effectiveness of acupuncture therapy compared with conventional drug therapy for PSVT [n = 203; relative ratio (RR), 1.18, 95% confidence interval (CI) 0.78–1.79; I2 = 80%; P = 0.44; Figure 2A].

Acupuncture + Drug vs. Conventional Drug Therapy for Ventricular Premature Beat (VPB)

The results of the meta-analysis of these five RCTs showed a statistically significant benefit of acupuncture plus the oral administration of AAD on the response rate compared with the oral administration of AAD alone for VPB (n = 286; RR, 1.15, 95% CI 1.05–1.27; I2 = 0%; P = 0.002, Figure 2B).

Acupuncture vs. Control Treatment (Neither Acupuncture nor Any Other Anti-arrhythmic Treatment) for Sinus Tachycardia

The results of the meta-analysis of these two RCTs showed a statistically significant benefit of acupuncture on the response rate compared with the control treatment (neither acupuncture nor any other anti-arrhythmic treatment) for ST (n = 120; MD, 18.80, 95% CI 12.68–24.92; I2 = 81%; P < 0.00001, Figure 2C).

The Risk of Bias

A review of the authors' judgments about each risk of bias item presented as percentages across all of the included studies. The quality of the selected studies was assessed according to the Cochrane criteria (Figures 34Higgins and Altman, 2008).

FIGURE 3

 

Figure 3. The risk of bias. A review of the authors' judgments about each risk of bias items are presented as percentages across all of the included studies. The quality of the selected studies was assessed according to the Cochrane criteria.

FIGURE 4

 

Figure 4. The risk of bias summary. A review of the authors' judgments about the risk of bias is included in each study.

Publication Bias

Funnel plot and Egger's test of publication bias were made for each analysis. However, as the number of included studies was small, the result might not be completely accuracy (Figure 5, Table 2).

FIGURE 5

 

Figure 5. Funnel plot for publication bias [(A) PSVT; (B) VPB].

TABLE 2

 

Table 2. Egger's test of publication bias for PSVT and VPB.

4bacdd3bb2b5761447bdd29ac221a688.jpg
VR-BASED 

For the Next Generation of Health Practitioners

A Map

Specializing in immersive VR anatomy
learning and simulation training

Learn More

 B Map

Revolutionizing the future of
acupuncture training

Learn More

C Map

Engaging patients with their Digital Twin
for modern patient education

Learn More

WHY 

Our comprehensive VR-based learning solutions can be used at any stage of your medical journey

Practitioners

Refine procedural techniques prior to performing certain procedures on actual patients​

Educators

No longer rely on 2D textbook images to teach concepts best understood through 3D visualization

Students

Better memorize and retain anatomy knowledge through realistic VR immersion

Patients

Better understand health conditions through immersive medical image visualization

WHO WE WORK WITH

Together with an ecosystem of technology and solution leaders, MAI offers a full suite of software solutions to transform the field of medical and patient education

ALLPARTNERSCOLLABORATIONSCLIENTS

CUSTOM PROJECTS

MAI provides custom solutions tailored to your specific needs. We welcome your requests regarding product customizations or custom projects for your specific teaching, learning, or research needs.

Our company has experience working with clients from beginning to end to deliver a wide range of custom projects. Examples of project types we provide and have completed for clients in the past include tailor-made solutions for pre-operative surgical planning, providing live or video product demonstrations for health seminar events, building a proton therapy virtual simulator, and developing an e-learning portal.

Learn More

Previous

Next

 

7d2723cc5a77e31acce5f1d64be42a53.jpg

Specializing in immersive VR anatomy and simulation training

WHAT IS BODYMAP

Experience a fully immersive 3D exploration of the human A

Map is a medically accurate representation of the human A that can be manipulated in 3D virtual reality. Our strict data reconstruction and design methods set us apart and provide users with realistic visualizations of every detail of the human body. Users may interact with the virtual body in numerous ways, including walking into the virtual body for a detailed inspection of internal organs, grabbing out anatomy structures for a closer look, and simulating instrument insertion techniques with instant haptic feedback.

CHOOSE BODYMAP IF YOU ARE

A clinical educator

Develop more effective teaching methods and improve curriculum based on student quiz feedback. Increase student engagement and interaction through instant and shared viewing. Design visually appealing lectures using screenshots or animations captured from our application.

A clinical provider

Practice procedural techniques such as injection simulations prior to performing on actual patients.

A researcher

Conduct research studies to assess how VR- and technology-based solutions affect cognitive behaviors and information retention.

An institution

Attract students looking for technology-based learning solutions to enhance traditional teaching methods. Reach more students remotely so that those not in physical attendance may still participate in learning.

Key Features

Medical Accuracy

Medically accurate reconstruction of human body systems based on real MRI and CT scans for effective anatomy learning

Comprehensive Content

Comparison of 12 main body systems in both male and female genders

Haptic Simulation

Haptic simulation training for performing insertion, injection, and cutting techniques

 

Question Bank

Question bank of 3000 anatomy quiz questions and categorized result feedback to assess understanding

 

Instant Magnification

Instant magnification and visualization tools during simulation training, with depth and angle of instrument insertion, e.g., syringe, displayed in real time

 

Multi-Player

Multi-player use with instant sharing of medical knowledge between instructors and students in real time

Fully Customizable

Contact us for any requests you may have for customization of BodyMap features. Examples of solutions we can provide include the design of different surgical tools for simulation of cutting actions, building of step-by-step instructions for procedures such as central venous catheterization (CVC), and creation of custom anatomy content or quizzes.

Still curious about the best way to learn anatomy?
Start your virtual journey today!

Book a Demo

Start Your Trial

Custom Projects

Our company has experience working with clients to deliver a wide range of custom projects. Whether it’s creating 3D VR reconstruction of patient-specific CT and MRI scans for surgical planning, assisting clients with live or video product demonstrations for health seminar events, or other project types listed below, MAI is ready to take on your project requests.

Pre-operative Surgical Planning

Client: Taipei Veterans General Hospital
Year: 2017

Our team at MAI performed 3D VR reconstruction of an actual patient’s CT and MRI scans for the purpose of pre-operative skull base surgical planning at Taipei Veterans General Hospital. This allowed the surgeon to better visualize the location of the lesion and simulate surgical procedures in an immersive VR environment prior to actual operation.  The surgeon also used MAI’s flagship product, BodyMap, as anatomy teaching material to interns and residents.

Live or Video Product Demonstrations for Health Seminar Events

Client: United Daily News     
Year: 2019

When United Daily News Group (UDNG) hosted a health seminar on the topic of stomach cancer at Eslite Bookstore in Xinyi, Taipei, MAI assisted in providing a live demonstration of BodyMap’s ability to let users visualize the length of the gastrointestinal (GI) tract involved during a simulated upper GI endoscopy procedure. 

This live demonstration facilitated the gastroenterologist guest speaker’s efforts in educating the audience about the importance of endoscopic screenings in early detection of stomach cancer and preventive measures.

MAI also produced a video demonstration of the same simulated procedure in case of any technical difficulties encountered during the live demonstration.

Proton Therapy Virtual Simulator

Client: Chang Gung Proton Therapy Center    
Year: 2017

MAI built a Proton Therapy virtual simulator for the purpose of treatment planning and collision prevention so that staff at Chang Gung Proton Therapy Center could better determine the optimal positioning of patients and simulate beam delivery prior to initiating proton therapy. 

VR reconstruction of the proton therapy gantry treatment room, equipment, and individual patient DICOM-RT images along with AI algorithm application for path planning and collision avoidance allowed staff to avoid potential collision of the rotating gantry with the couch and/or patient. The goal of this project was to decrease preparation time prior to initiating proton therapy and increase patient safety during treatment.

Institutional E-learning Portal

Client: Beijing University of Chinese Medicine (BUCM) 
Year: 2018 – present

MAI is assisting Beijing University of Chinese Medicine (BUCM) to develop an online teaching portal for institutional use so that they may upload videos that they record using our VR-based acupuncture training solution (AcuMap). The goal of this initiative is to provide an e-learning portal to increase access to teaching and learning for educators and students within the institution.

In addition, BUCM is currently integrating this acupuncture training solution into the curriculum to teach students, within an immersive VR learning environment, how to more effectively identify and simulate needle insertion into high risk and dangerous acupoints.

Our acupuncture training solution was awarded as the sole national acupuncture training program in China.

We also welcome any requests for custom projects not listed in the project categories above. Please contact us to learn more.

34c5622c830c23c6f39dd51fc958521c.jpg

onverts 2D patient medical images (MRI, CT scans) into 3D virtual images in less than 30 seconds. This technology allows clinicians to engage patients with their Digital Twin for improved patient education and shared decision making processes leading to better treatment plans.

CHOOSE DIGITWIN IF YOU ARE

– A clinician

Better connect with and educate patients so as to more efficiently reach shared decisions and formulate appropriate treatment plans.

– A clinic or wellness center

Attract patients who wish to spend more time with their health providers to learn about their health conditions in detail and take part in treatment decisions.

Key Features

Fast conversion

Convert patient diagnostic images (e.g., MRI, CT scans) into 3D virtual images in less than 30 seconds

Hassle-free interface

Our platform allows clinicians to observe what the patient is seeing and how the patient is interacting with his or her Digital Twin in real time

Image fusion

Image fusion technology to improve image quality and reduce randomness and redundancy

Measuring tools

Precision measuring tools to measure dimensions of regions of interest in patient images

Annotation tools

For better understanding of certain regions of interest

Sharing

Instant sharing of medical knowledge and patient information among clinicians in real time

 

Digital Twin Case Study at LANDSEED Healthcare Center

from MAI

Still curious about the best way to engage with patients? Start your virtual journey today!

Revolutionizing the future of acupuncture training

WHAT IS ACUMAP

Visualize meridian pathways and acupoints which are otherwise invisible to the naked eye

Leveraging proprietary BodyMap technology, AcuMap allows users to overlay meridian pathways and acupoints against human anatomical systems of the body, and also simulate acupuncture techniques on various acupoints with instant haptic feedback and interactive visualization tools including depth information and angle insertion readings.

CHOOSE ACUMAP IF YOU ARE

An educator of acupuncture

Overcome limitations of teaching with traditional acupuncture manikins, conduct more effective dry needling training.

A practitioner of acupuncture

Refine specific needling procedures prior to initiating treatment on actual patients.

A researcher

Conduct research studies to assess how VR- and technology-based solutions affect cognitive behaviors and information retention.

An institution

Attract students looking for technology-based learning solutions to enhance traditional teaching methods. Reach more students remotely so that those not in physical attendance may still participate in learning.

Key Features

300+ Acupoints

Visualization of 300+ acupoint locations along 14 Traditional Chinese Medicine meridian pathways

14 Meridians

Comparison of 14 Traditional Chinese Medicine meridian pathways against 12 main body systems

Haptic Simulation

During acupuncture needling simulations, users receive light haptic feedback when piercing through the skin and strong haptic feedback when hitting bone

 

Question Bank

Question bank of 3000 anatomy quiz questions and categorized result feedback to assess understanding

 

Instant Magnification

Instant magnification and visualization tools during simulation training, with depth and angle of instrument insertion, e.g., syringe, displayed in real time

 

Multi-Player

Multi-player use with instant sharing of medical knowledge between instructors and students in real time

Still curious about the best way to learn acupuncture? Start your virtual journey today!

Book a Demo

Start Your Trial

8a81148fb51292588f08b61af5c6dfed.jpg
image.img.jpeg
32cf8633ca0085b64323a9b46211ddd6.jpg
20b37cf7af89015b4a36059bb4229844.jpg
522d72bfb8428e046fb0e28956af2872.jpg
e3de6296aacdd5eb1c3d9876d9a786be.jpg
f334e9ce57996a9a4715aedd1d4802a4.jpg

Welcome to the entrance to the world of acupuncture
Acupuncturist: a profession that will not disappear in the AI ​​era
With the development of AI (artificial intelligence), many existing occupations are expected to disappear. It is said that artificial intelligence has gradually entered the high-level intellectual professional fields such as finance and legal affairs, and has begun to serve people.

But what about acupuncture?

Acupuncture is a delicate and special technique that cannot be easily replaced by computers or machines. It can only be done manually. We often hear about their physical conditions from patients, consider the cause of the current symptoms, and select appropriate treatment points from 361 acupoints (acupoints) for acupuncture. This is a complex and delicate technique. It is impossible for robots. Even if it is possible, it will not be controlled by practitioners.

On the contrary, since it is surrounded by digital devices every day, do you think it needs the warmth, softness and safety of human hands? Acupuncture is a technology that is expected to become more valuable in the future AI era.

The WHO (World Health Organization) has also certified the therapeutic effects of acupuncture. Acupuncture therapy is good at treating symptoms that are difficult to improve by Western medicine, pain that has not been diagnosed as "discomfort" (discomfort) according to the examination results, and pain that cannot be completely cured. It is understandable that in recent years, the upsurge of Oriental medicine is coming, and it is said that this is a very stressful society. There is a growing demand for acupuncturists who can understand and treat patients' pain.

In addition, acupuncturists are long-term participants of men and women. This is not hard work, so even after aging, you can use the skills and intuition accumulated according to your physical strength to stand in the field of treatment. This is a lifelong job, you can improve your skills while you work, and cultivate opportunities for success while reaping rewards.
 

ACCELERATE OUTCOMES WITH A BACKBONE FOR ARTIFICIAL INTELLIGENCE.

makes machine learning operational by connecting models to the real-world decisions they inform. Often, AI/ML algorithms live in experimental vacuums. Foundry provides the end-to-end infrastructure an organization needs to apply AI/ML to real problems and real data:

  • A data foundation.  provides the data engineering capabilities an organization needs to deploy AI/ML models it can trust. Organizations use  to build a solid foundation of sufficient, quality data, then bring that data into daily operations.

  • Production deployment infrastructure. revolutionizes the way organizations build and deploy AI/ML by combining a data foundation with end-to-end algorithm deployment infrastructure. Data scientists and engineers can customize, deploy, assess, and compare across homegrown, open-source, and third-party algorithms. All models are tightly integrated with end-to-end platform capabilities, ranging from feature curation and health checks to model management to inference/serving to outcome monitoring.

  • Faster feedback loops. AI/ML models rarely work on a "set it and forget it" basis.  integrates the full model lifecycle with end user actions and feedback, and with operational decisions and outcomes. This enables operationally oriented model monitoring, management, understanding, selection, and adjustment. The result is more adaptable and ambitious AI/ML, faster.

UNITE THE ORGANIZATION AROUND A SHARED ENVIRONMENT FOR MACHINE LEARNING.

The most effective AI/ML encodes and supercharges an organization's unique expertise. That requires uniting an organization's data scientists, decision-makers, and everyday employees in an environment for collaborating on AI/ML-powered operations.  collaboration infrastructure drives AI/ML that brings the organization together:

  • A unifying ontology. ontology translates an organization's complex data landscape into human-readable concepts. built models reflect how an organization views the world and unite data scientists, engineers, analysts, executives, and operational end users around a common semantic layer.

  • Granular security controls. lets organizations define granular access control policies at the integration stage, then propagates those policies intelligently across the system. Organizations can promote collaboration confidently with granular data security and transparent data governance.

  • Model templates.model templates empower low-code and no-code AI/ML so even non-technical users can use AI to accelerate and enrich their workflows.

MAXIMIZE IMPACT AND MINIMIZE RISK WITH A PLATFORM DESIGNED FOR RESPONSIBLE ENGINEERING.

Our approach to AI/ML in  reflects our foundational belief in augmenting human intelligence, not replacing it. We believe AI/ML algorithms are most effective when they empower humans to ask complex questions, interpret answers, and act on results. At public and private sector organizations around the world, driven AI/ML is accelerating human decision-making by:

  • Surfacing new leads in dark web, weapons trafficking, financial fraud, and drug trafficking investigations so investigators can identify persons of interest more quickly

  • Aggregating and correlating biomedical research data to streamline drug discovery

  • Processing entity resolution suggestions so analysts can focus on making assessments rather than manually sorting and tagging data

  • Analyzing massive-scale sensor data so that engineers can make better aircraft maintenance decisions

  • Rapidly generating simulations while allowing operators to tweak scenario variables, leading to better-informed decisions optimized for different variables (e.g., safety rating and production quantity)

I see our approach to ethical machine learning as being grounded in an appreciation for both the promise and limitations of human-computer collaboration. The promise of AI is in augmenting and enhancing human intelligence, expertise and experience. Think helping a aircraft mechanic make better, more accurate and more timely repairs – not automating the mechanic out of the picture.

— Anthony Bak, Co-Lead of Palantir's Machine Learning team, in an interview with CTOVision

Protecting privacy and preserving civil liberties is fundamental to our mission.ships with technical capabilities that enable ethical engineering and ethical machine learning, including data protection features such as granular access controls, data provenance and lineage tracking, data retention and deletion management, and audit logging.  also enables industry-leading monitoring and validation for AI models. Its flexible, configurable tools let organizations evaluate model bias, in terms of both the data used to train the model and model outcomes.

We recognize that technology alone can't fully mitigate the risks of machine bias. Our dedicated Privacy and Civil Liberties team works with our engineers and our customers to approach building and deploying AI/ML thoughtfully.

Acupuncture significantly reduces AI-associated arthralgias

Publish date: December 8, 2017

By 

Roxanne Nelson

 

 

 

REPORTING FROM SABCS 2017

SAN ANTONIO – Acupuncture significantly reduced joint pain that was associated with the use of aromatase inhibitors (AIs) in women with early breast cancer, according to new findings reported at the San Antonio Breast Cancer Symposium.

The randomized, phase 3 SWOG S1200 clinical trial found that, compared with sham acupuncture and a control group receiving no therapy, women receiving acupuncture reported significantly lower scores on the Brief Pain Inventory–Short Form (BPI).

“We have shown consistently, with multiple measures assessing pain and stiffness, that true acupuncture generated better outcomes than either control group in a large multicenter trial,” said lead author Dawn L. Hershman, MD, leader of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center. “Acupuncture provides a nonpharmacologic option that can improve symptoms and possibly increase AI adherence and subsequent breast cancer outcomes.”

AIs can reduce both early breast cancer recurrence and mortality. Dr. Hershman noted that these agents are effective in the adjuvant setting and for prevention “but we know that it doesn’t work if you don’t take it. Noncompliance is a major problem among women taking hormonal therapy.”

Noncompliance is multifactorial and one of the main reasons women discontinue their therapy early is because of arthralgias or joint discomfort. “We were interested in a nonpharmacologic intervention, to assess whether or not we could control these symptoms.”

Dr. Hershman pointed out acupuncture provides a safe and effective alternative for patients reluctant to take a prescription medication that can result in other side effects. “Identification of nonopioid options for pain control is a public health priority,” she said.

Acupuncture is a popular nonpharmacologic modality and widely used for a number of indications. Several single-institution studies have suggested that it may be useful for controlling AI-associated arthralgias, while other studies have not demonstrated a benefit.

In this trial, the authors evaluated the efficacy of acupuncture, compared with sham acupuncture or waitlist control, in the treatment of AI associated arthralgia in a large population of patients. The study was conducted at 11 centers.

The cohort comprised 226 postmenopausal women diagnosed with early-stage, hormone receptor–positive breast cancer who were receiving treatment with AIs. The primary endpoint was the decline in joint pain as measured by BPI-SF at 6 weeks, and to assess the duration of the effect, the women were followed for an additional 12 weeks.

Within this group, 110 were randomized to true acupuncture; 59 to sham acupuncture, and 57 to waitlist control (no treatment). Patients receiving true or sham acupuncture had sessions three times a week for 6 weeks followed by one session per week for 6 more weeks. Pain status was reported at baseline, during treatment, and then afterwards, using a variety of measurement tools including the BPI-SF, which is a self-administered 14-item questionnaire that evaluates pain severity on a 0-10 scale, and the impact of pain on activities of daily living.

At 6 weeks, the true acupuncture treatment arm reported significantly lower BPI worst pain scores than those in the sham acupuncture and the waitlist control arms. The mean BPI worst pain for the true acupuncture arm was 0.92 points lower than the sham acupuncture arm (P = .01) and 0.96 points lower than the waitlist control arm (P = .01). The proportion of patients experiencing a large reduction in BPI worst pain (greater than 2) was significantly greater in the true acupuncture arm, compared with the other groups: 58% versus 33% percent and 31%, respectively. The differences continued to remain statistically significant at 24 weeks, even though the treatment only continued for 12 weeks.

Associated adverse effects were minimal with true and sham acupuncture and limited to grade 1 bruising.

The cost of the 12-week intervention was about $1,250 or $65-$75 a session. “We feel that there is now sufficient evidence to support insurance coverage of acupuncture of AI arthralgia.”

In a discussion of the paper, Dr. Anne Partridge, from the Dana Farber Cancer Center, noted that it is imperative to seek new ways to improve outcomes in breast cancer, and AIs are contributing to that. However, she echoed the concern that nonadherence to treatment is a “tremendous problem” and hampers the clinical effectiveness of AI therapy.

The rate of discontinuation during the first year of therapy is 20% within the first year and up to 40% of patients do not take them daily. Both early discontinuation and nonadherence contribute to mortality.

Based on these results from the largest randomized controlled trial looking at acupuncture in this setting, should physicians be recommending acupuncture to patients prescribed AI therapy?

“The short answer is, why not?” said Dr. Partridge, “And that we should be recommending it for some of our patients.”

However, there are a number of issues that need to be addressed, she added. The duration of treatment is not known, and the need for follow-up treatment or the frequency of it is not known. The generalizability of it is also unclear when looking at a larger population, and acupuncture is highly operator dependent.

“There are cost and access issues, and insurance right now offers very limited coverage,” she said.

Importantly, Dr. Partridge emphasized, “We know that it will help symptoms, but will it improve adherence to AI?”

It may improve adherence for some patients, but “side effects are only one factor,” she said. “Adherence behavior is complicated. We need to figure out how to optimize these therapies in our patients.”

This study was supported by the National Institutes of Health National Center for Complementary and Integrative Health and the Office of Research on Women’s Health, and grants from the NIH/National Cancer Institute Division of Cancer Prevention. Dr. Hershman declared no conflicts of interest. Dr. Partridge had no disclosures.

empty-wheelchair-parked-in-hospital-pict
digitwin.png

Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study

Apr 23, 2019

 

staff reporter

 

NEW YORK (GenomeWeb) – Illumina and the Children's Hospital of Fudan University in China plan to launch a study of whole-genome sequencing in the hospital's neonatal intensive care unit to determine whether it can be used as a diagnostic for critically ill infants, Illumina said this week.

According to Illumina, the researchers plan to enroll 200 patients and compare the diagnostic rate of rapid WGS with genetic diagnostic methods such as microarray analysis and gene panel sequencing.

The researchers will also compare the time it takes to reach a diagnosis, impact on the patient's prognosis, and turnaround time.

Illumina will provide the sequencing reagents and the Children's Hospital of Fudan University will conduct the testing and data analysis and also be responsible for reporting results and providing genetic consultations with family members.

The hospital is also a sponsor of the Newborn Genome Project, which is creating a genome database for newborns in China in order to develop better methods for detecting genetic diseases in newborns and to establish standards for neonatal genetic diseases.

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

Dec 13, 2019

 

staff reporter

 

NEW YORK – Researchers from the Institute of Cancer Research, London and the Royal Marsden NHS Foundation Trust have presented data demonstrating that blood-based genotyping assays can accurately detect specific biomarkers and potentially be used to guide targeted treatment of metastatic breast cancer. 

The researchers used Guardant Health's liquid biopsy assay and Bio-Rad Technologies' droplet digital PCR (ddPCR) testing to identify errors — including mutations in the HER2, ESR1 and AKT1 genes — in circulating tumor DNA (ctDNA) that had been shed into the patients' bloodstream. 

During a presentation this week at the San Antonio Breast Cancer Symposium (SABCS), Nicholas Turner, molecular oncology professor at the Institute of Cancer Research, explained that his team wanted to solve the issue of genotyping breast cancer tumors without having to perform multiple biopsies. Turner highlighted the need for prospective studies to assess the accuracy of ctDNA testing in routine practice and the potential of these tools to guide targeted therapy without requiring solid tissue testing. 

With funding from Stand Up To Cancer (a fundraising campaign from Cancer Research UK and Channel 4) Turner's team therefore launched an ongoing prospective study, called "plasmaMATCH," to examine the clinical utility of ctDNA for metastatic breast cancer detection. The group enrolled a total of 1,044 patients with advanced breast cancer who had either progressed on prior drug therapy or relapsed within a year after adjuvant chemotherapy. 

The researchers analyzed ctDNA in blood samples from patients using the Guardant360 sequencing-based assay and Bio-Rad's ddPCR as an orthogonal method. Patients with identified mutations could also enroll in a treatment arm of the study that matched their mutation. 

Turner and his team split the patient population into three major cohorts depending on specific genetic errors found in ctDNA: ESR1 mutations, HER2 mutations, and AKT-1 mutations in estrogen-receptor-positive breast cancer. The researchers also added a fourth cohort that had AKT-1 and PTEN mutations based on both ctDNA and tumor sequencing results, as well as a fifth group with triple-negative breast cancer without mutations. 

While Turner's team's initially aimed to measure the response rate of targeted therapies matched to mutations in ctDNA without tissue testing, the researchers also monitored the frequency of mutations, accuracy of testing, proportion of patients entering a treatment cohort, and the activity in clonality-dominant versus subclonal mutations. Turner's team discovered that 784 patients who had cfDNA testing done with both Guardant360 and ddPCR had "very strong agreement" of between 96 and 99 percent. Comparing the ctDNA to the patients' tumor samples to validate the plasmaMATCH findings, the researchers found that the liquid biopsy assay had an overall sensitivity of 93 percent. 

Guardant360 also identified several more targetable alterations than hotspot testing, including over 35 percent more PIK3CA mutations that can be targeted by US Food and Drug Administration-approved therapies. The assay also detected significantly more ESR1 mutations and found previously undetected microsatellite instability and ERBB2 mutations.   

The researchers provided 142 patients that had specific identified mutations experimental targeted therapies as part of the study, and they plan to test the treatments that showed initial promise in larger clinical trials. 

The researchers now believe that they can use blood testing to identify rare subtypes of breast cancer, in addition to potentially replacing more invasive methods of breast cancer detection. 

"We have now confirmed that blood tests can quickly give us a bigger picture of the mutations [that] are present within multiple tumors throughout the study," Turner said in a statement.  

"We show that circulating tumor DNA testing offers a simple, efficient, and fast method of tumor genotyping," Turner also noted during the presentation at SABCS. "The patients with mutations identified in their ctDNA have efficacy with matching target[ed] therapies." 

The researchers believe the blood-based assays are now reliable enough to be applied routinely by clinicians after receiving regulatory approval.

"As the number of treatment-relevant genomic alterations in metastatic breast cancer continues to grow, it is critical that oncologists have a simple and reliable way to comprehensively test for this information about their patients," Guardant Health Global Chief Medical Officer Rick Lanman said in a statement. "Guardant360 detected changes in the genome picture over time … and also identifies targetable but uncommon genomic biomarkers."

1c8b9b577cc41266ebab5e65ff8f3de8.jpg
090320_COVID_Test_0111-1024x682.jpg
05b50bc878af8f403a01848035fa3a86.jpg
7d54e3018152c4d0b389e55596039404.jpg
4deac0802d4054a8a85b3f3d256911aa.jpg
hocit999 - コピー_ページ_16.jpg
hocit999_ページ_6.jpg
bottom of page